brodalumab
immunoglobulin G2-kappa, anti-[Homo sapiens IL17RA (interleukin17 receptor A, CD217)], Homo sapiens monoclonal antibody
Facts
10 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound
- Has use
- medication[4]
- Defined daily dose
- 15 mg[11]
- Legal status (medicine)
- boxed warning[10]
- LiverTox likelihood score
- LiverTox toxicity likelihood category E[12]
- Physically interacts with
- Interleukin 17 receptor A[3]
- Subject has role
- dermatologic drug, monoclonal antibody[8][9]
🏷️ Also known as
en brodalumab
en Siliq
ar برودالوماب
cs Siliq
cs Kyntheum
fa برودالومب
ja ブロダルマブ
ru Бродалумаб
zh 布羅達魯單抗
🔖 Identifiers · 16
- ATC code
- L04AC12
- CAS Registry Number
- 1174395-19-7
- DrugBank ID
- DB11776
- Freebase ID
- /m/0h561_2
- Guide to Pharmacology Ligand ID
- 7540
- KEGG ID
- D10061
- LiverTox ID
- Brodalumab
- MeSH descriptor ID
- C571216
- MedlinePlus drug identifier
- a617009
- Microsoft Academic ID (discontinued)
- 2778131255
- PatientsLikeMe treatment ID
- brodalumab
- RxNorm CUI
- 1872251
Show all 16 identifiers +4
- UMLS CUI
- C3491331
- UNII
- 6ZA31Y954Z
- WikiProjectMed ID
- Brodalumab
- World Health Organisation international non-proprietary name numeric ID
- 9475
🔗 Connections
Has use 1
Legal status (medicine) 1
Medical condition treated 1
Subclass of 1
Subject has role 1
Press Enter · cited answer in seconds